CURRENT ISSUE
BACK ISSUES
SUBSCRIBE
ADVERTISE
ABOUT JCEHP
FOR AUTHORS
JCEHP AWARD
SEARCH
|
|
Volume 18 (2)
Volume 18, Issue 2, Spring 1998
J Contin Educ Health Prof 1998; 18(2):100-106
ORIGINAL ARTICLES
Identification of Individuals with Elevated Cholesterol in Family Physicians’ Offices
Wayne Putnam, MD, CCFP, FCFP
Karen Mann, PhD
Elizabeth Lindsay, PhD
David Davis, MD, CCFP, FCFP
A b s t r a c t
Guidelines for screening for elevated serum cholesterol have been published in both
Canada and the United States. Preventive practices have been difficult to integrate into episodic
care. This study was designed to test the impact of an educational intervention to increase physicians’ screening
for elevated cholesterol in their practices. It was hypothesized that physicians who
participated in the intervention would demonstrate higher rates of appropriate screening. A three-group
randomized controlled trial of an educational intervention was conducted over 10 months
in family physicians’ private offices throughout Nova Scotia. Invitation letters were mailed to full-time
family physicians with 5 or more years in practice. Fifty-nine (27.2% of 217 eligible) physicians
entered and 51 completed the study. The study group physicians attended a half-day workshop
emphasizing information regarding, and approaches to, screening. The primary outcome measure
was of physician screening in their practice. The baseline preworkshop screening rate averaged
51.7% for all groups. The groups were similar in this regard (p = .14). Physicians in the two study
groups who attended the workshop had higher postworkshop screening rates than the control group
(p = .08). The lack of strongly statistically significant effects of the intervention may be deceiving
when the high base screening rate and the high physician within-group variability are considered.
Attempts to evaluate the impact of interventions must take into account the very large amount of
information directed at physicians and the public regarding elevated cholesterol.
Keywords: Cholesterol; Continuing Medical Education (CME); Physician, Family; Practice Guideline;
Screening
|